关于多发性硬化症患者5年预后的奥利戈克隆带
Masoud Ghiasian1, Mojtaba Khazaei1, Sajjad Daneshyar1
1Department of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Caspian journal of internal medicine
|June 27, 2025
概括
多发性硬化症 (MS) 患者的橄克隆带 (OCB) 不能预测长期残疾. 然而,OCB阴性多发性硬化症患者在五年内复发率更高.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床研究 临床研究
背景情况:
- 多发性硬化症 (MS) 是一种自身免疫性中枢神经系统 (CNS) 疾病.
- 预后标志物对于管理MS进展至关重要.
- 在多发性硬化症中,橄克隆带 (OCB) 的预后作用需要进一步研究.
研究的目的:
- 评估OCBs在短期MS进展中的预后价值.
- 评估OCB状态和MS患者的临床结果之间的关系.
主要方法:
- 一项为期五年的复发性复发性多发性硬化症患者的随访研究.
- 扩展残疾状况量表 (EDSS) 评分的监测.
- 在OCB阳性和OCB阴性组之间对临床表现的比较.
主要成果:
- 分析了140名多发性硬化患者,71%的患者呈OCB阳性,29%的患者呈OCB阴性.
- 在OCB组之间,基线特征或五年EDSS进展没有显著差异.
- 在OCB阴性患者中,出现了统计学上显著的更高的平均复发率 (1.37对1,P=0.03).
结论:
- 在五年内,OCB似乎不是MS残疾进展的显著预后标志物.
- OCB状态可能会影响MS复发的频率.
- 需要进一步的研究,以了解OCBs在MS病原和临床过程中的复杂作用.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20


